ClinicalTrials.gov
public full text
Public Domain
A 6 Month Safety Extension Study of MBGS205
Phase IIb, multicentre, double-blind, randomised, placebo-controlled parallel-group 36-week study evaluating safety and efficacy of BGS649 in male obese subjects with hypogonadotropic hypogonadism (HH)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men#886342
- Study of the Prevalence and Associated Factors With Hypogonadism in HIV + Men#899915
- Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: A randomized controlled trial#1005394
- The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive Implant#1350889
- The Effect of a Gastric Bypass on Type 2 Diabetes in the Morbidly Obese Patient#833074
Record · ID 1228252
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive